Constitutively activation of Smo increased CML stem cell number and accelerated disease (Zhao et al., 2009), while the loss of Smo impaired HSC renewal (Strathdee et al., 2007). Here, SMO is linked to chronic myelogenous leukemia, BCR-ABL1 positive.